Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1621
SPL treatment decreases diabetes-induced decrement in protein expression of cldn-5 in glomeruli (GL) and cldn-2 and occldn in proximal tubules (PT).
Published 2017“…<p>SPL prevents diabetes-induced decrease of cldn-5 protein expression (A and B) in GL, and mRNA (F) and protein expression of cldn-2 (A and C), and protein expression of occldn (A and D) in PT (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s002" target="_blank">S2 Fig</a>). …”
-
1622
Cellular stress decreases TDP-43 levels in patient neurons with the TDP-43 A90V mutation.
Published 2013Subjects: -
1623
-
1624
-
1625
-
1626
-
1627
CNP decrease mitochondrial membrane potential and induce mitochondrial fragmentation in melanoma cells.
Published 2020“…C, Quantification of melanoma and melanocyte mitochondrial morphology after treatment with CNP or CCCP for 24 h according to Duvezin-Caubet et al. [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0227926#pone.0227926.ref047" target="_blank">47</a>]: tubular (>5 μm), intermediate (0.5–5 μm), fragmented (< 0.5 μm). …”
-
1628
-
1629
EphA4 immunostaining is decreased adjacent to injury site in ephrin-A5-Fc treated mice.
Published 2011“…<p>Immunohistochemical analysis of (A,B) GFAP, (C–F) EphA4 and (G,H) CSPG expression at 2 weeks after spinal cord hemisection and 2 weeks of ephrin-A5-Fc treatment indicated that there was robust GFAP staining in both treated and control mice (A,B). …”
-
1630
-
1631
-
1632
-
1633
-
1634
-
1635
Sarcopenia as an Independent Risk Factor for Decreased BMD in COPD Patients: Korean National Health and Nutrition Examination Surveys IV and V (2008-2011)
Published 2016“…<div><p>Background</p><p>A decrease in bone mineral density (BMD) is a systemic consequence of chronic obstructive pulmonary disease (COPD). …”
-
1636
-
1637
-
1638
-
1639
-
1640